TickerFactsScreenerDevelopers

Vanda Pharmaceuticals Inc. (VNDA) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $39.08M2009: $205.29M2010: $42.56M2011: $87.92M2012: $88.77M2013: $64.76M2014: $60.90M2015: $50.84M2016: $40.43M2017: $33.63M2018: $61.01M2019: $45.07M2020: $61.03M2021: $52.07M2022: $135.03M2023: $135.82M2024: $102.32M2025: $84.85M$84.85M
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$84.85M-17.1%
2024$102.32M-24.7%
2023$135.82M+0.6%
2022$135.03M+159.3%
2021$52.07M-14.7%
2020$61.03M+35.4%
2019$45.07M-26.1%
2018$61.01M+81.4%
2017$33.63M-16.8%
2016$40.43M-20.5%
2015$50.84M-16.5%
2014$60.90M-6.0%
2013$64.76M-27.0%
2012$88.77M+1.0%
2011$87.92M+106.6%
2010$42.56M-79.3%
2009$205.29M+425.3%
2008$39.08M—